A meta-analysis of the effects of the current GLP-1RAs on body weight, glycemic control, and lipid profile revealed that tirzepatide, a dual GLP-1RA and GIP-RA, has the highest efficacy in improving glycemic control compared to other GLP-1RAs, suggesting a beneficial effect of targeting the GIP-R along with the GLP-1R
This is why we recommend baseline examination before starting therapy and ongoing monitoring throughout your treatment course, not just in the initial months
Alternatives with short refund windows or unclear return rules raised more complaints in 2025 consumer reviews
Health Conditions: If you have health conditions like diabetes or high blood pressure our programs can be modified to accommodate these so you can lose weight safe and effective
Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI
At the 12 mg dose over 48 weeks, participants lost an average of 24.2% of their body weight